Editor’s Perspective
-
6.0KMiSight® 1 Day FDA Approval: Why It Matters
MiSight® 1 day’s FDA approval is an important step forward in stopping the myopia epidemic facing American children.
-
5.9KAn Important New Approach to Managing Progressive Myopia
Results of a recent study on combining orthokeratology and topical atropine 0.01%.
-
6.9KBeware of Snake Oil
When I speak with eye care professionals I am surprised by how much snake oil exists.
-
5.3KThank You, Global Myopia Awareness Coalition
Jobson Optical Research, sponsored by Essilor, polled more than 300 optometrists in the U.S.
-
3.7K‘What Happens If I Do Nothing?’
Myopia was once considered a simple refractive error with few, if any, long-term eye health consequences.
-
2.5KOpportunities Abound for Proactive Myopia Care
July 1, 2019 By Dwight Akerman, OD, MBA, FAAO Chief Medical Editor, Review of Myopia Management During May 2019, Jobson Optical Research,...
-
3.3K
Focus On What We Know, Not What We Don’t Know
While we have much to learn about myopia management in children and teenagers, we already know so much.
-
2.6KProactively Addressing Progressive Myopia
Congratulations to all who created the International Myopia Institute (IMI) Myopia White Papers.
-
3.3KWhom to Target With Myopia Management Intervention?
Thank you for your support for Review of Myopia Management.
-
3.2KWhy is Myopia Management Important?
The answer comes from articles written by leaders in myopia care.